RankAlpha logo
Back to Rankings

RCUS

Arcus BiosciencesB
NYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
RCUS vs peer average
71/100
RCUS vs. peer average (B vs. C)
Grade spread
A 1 · B 1 · C 4 · D 2 · F 2
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

MRK is the first available peer comparator.

Merck is the closest mechanism benchmark because WELIREG is the approved HIF-2alpha reference in RCC, so Arcus must show casdatifan data strong enough to support a differentiated frontline and sequencing story.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerMRKMerck
RCUS
Arcus Biosciences
MRK
Merck
Grade
B
C
Momentum
59
82
Value
41
62
Sentiment
74
55
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Mixed

Grade position vs MRK

RCUS / MRK
Grade Position
Above peers
RCUS vs. peer average (B vs. C)
71/100
Momentum
59
MRK
Value
41
MRK
Sentiment
74
RCUS

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs RCUS
1
MRK
MRK
C
60/100
+1
2
EXEL
EXEL
C
60/100
+1
3
GPCR
Structure Therapeutics Inc ADR
D
40/100
+2
4
DNLI
Denali Therapeutics Inc Common
C
60/100
+1
5
ABCL
AbCellera Biologics Inc Common
F
20/100
+3
MRK is the first peer returned for this comparison set.